Woodstock, GA, June 09, 2017 – Tissue Regeneration Technologies, LLC (TRT) is pleased to announce that Major League Baseball team, The Cleveland Indians, has officially adopted SoftWaveTM technology via the TRT OrthoGold 100 series ESWT device, exclusively through AcousTek, LLC.
Many of The Indians’ players have benefitted from SoftWaveTM since the team began using the therapeutic technology in February 2017.
SoftWaveTM is a breakthrough patented non-invasive atraumatic treatment technology that activates endogenous musculoskeletal stem cells through proprietary high-energy unfocused electrohydraulically-produced acoustic pulses. It is proving to be the silver bullet in the sports med armamentarium across many sports specialties and in every day lives of people dealing with chronic and acute pain...
Read the entire press release here...
The potential for using low intensity shockwave therapy to treat erectile dysfunction (ED) was first proposed in 2010, and early studies have suggested that it may provide some benefits. However, the ideal energy levels and frequency of treatment are a matter of debate.
Two experts took up that debate during Sunday morning’s Prime Time plenary session in a 20-minute presentation moderated by Ranjith Ramasamy, MD, assistant professor and Director of Reproductive Urology at the University of Miami.
To read the rest of the debate click here
The Global Alliance for Regenerative Medicine, a world-renowned regenerative medicine clinic, announced today that it is now offering unfocused acoustic wave therapy (aka “GARM Wave”) for the treatment of musculoskeletal pain, inflamed and injured tissue, as well as for blood flow improvement. “This technology seems to bring about significant relief of patients’ pain from joint and soft tissue injuries, as well as pain form arthritis or tendonitis/tendonosis. In addition to rapid pain relief, the GARM Wave seems to contribute to reduced injury recovery time,” stated GARM’s Medical Director, Glenn C. Terry, M.D.
Read more here.
Woodstock, GA, April 19, 2016 – Tissue Regeneration Technologies, LLC (TRT) announces an Exclusive License Agreement with Acoustic Wave Cell Therapy, Inc. (AWCT), a Delaware Corporation, whereby AWCT will utilize TRT's extensive patent portfolio to develop and market low energy acoustic wave treatments for multiple internal organs and associated tissues and pathologies.
We have set up a Facebook and Twitter for the TRT community to get the latest updates!
TRT Announces Release of Patent that Opens New Doors for the Expansion of Shock Waves into Nonmedical Industries
Woodstock, GA, November 12, 2015 – Tissue Regeneration Technologies, LLC (TRT) today announces the issuance of patent number 9,060,525. With this new patent, TRT now owns the methodology of using shock wave technology to increase the amount of extract from cellular plant tissue. Modern industrial processes for extracting substances from plant cells are very inefficient and waste a lot of usable material. The use of shock waves, as patented by TRT, drastically increases the yield of such extraction processes.